Prognoses and Prognostic Factors of Carcinosarcoma, Endometrial Stromal Sarcoma and Uterine Leiomyosarcoma: A Comparison with Uterine Endometrial Adenocarcinoma
Authors:
- Jun-Ichi AkahiraJAJun-Ichi Akahira
- Hideki TokunagaHTHideki Tokunaga
- Masafumi ToyoshimaMTMasafumi Toyoshima
- Tadao TakanoTTTadao Takano
- Satoru NagaseSNSatoru Nagase
- Kosuke YoshinagaKYKosuke Yoshinaga
- Toru TaseTTToru Tase
- Yuichi WadaYWYuichi Wada
- Kiyoshi ItoKIKiyoshi Ito
- Hitoshi NiikuraHNHitoshi Niikura
- Hidekazu YamadaHYHidekazu Yamada
- Akira SatoASAkira Sato
- 1 January 2006
- journal article
- research article
- Published by S. Karger AG in Oncology
- Vol. 71 (5-6) , 333-340
Abstract
Aims: The aims of this study were to evaluate the factors affecting prognosis in patients with uterine sarcomas and to demonstrate that carcinosarcoma bears a similarity to high-grade endometrial carcinoma in terms of its prognosis and clinicopathological parameters. Methods: In June 2004, 17 Japanese institutions received questionnaires regarding uterine sarcomas. Study patients had uterine sarcomas initially treated at each institution between January 1990 and May 2004. Survival analyses and comparisons were performed by univariate methods. Patient data of 921 cases of endometrial adenocarcinoma were also analyzed and compared to the data with the uterine sarcomas. Results: One hundred twenty-one patients with uterine sarcomas were identified who met study eligibility criteria. In uterine sarcomas, carcinosarcoma had a worse prognosis than other sarcomas, but the difference was not significant (p = 0.302). In carcinosarcoma, significant differences were observed with age (p = 0.0388), stage (p < 0.01) and surgical procedure (with or without pelvic lymphadenectomy, p = 0.0316). In carcinosarcoma and G3 adenocarcinoma, no significant difference was identified with regard to overall survival in univariate (p = 0.191) and multivariate (p = 0.168) analyses. Conclusion: Our results demonstrate that the clinical behavior of carcinosarcoma strongly resembles that of G3 endometrial adenocarcinoma, setting it apart from other ‘pure’ uterine sarcomas.Keywords
This publication has 46 references indexed in Scilit:
- Lymphadenectomy for endometrial cancer: is paraaortic lymphadenectomy necessary?International Journal of Clinical Oncology, 2007
- Phase III Trial of Ifosfamide With or Without Paclitaxel in Advanced Uterine Carcinosarcoma: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2007
- Preoperative Diagnosis and Treatment Results in 106 Patients with Uterine Sarcoma in Hokkaido, JapanOncology, 2004
- Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomasInternational Journal of Gynecological Cancer, 2002
- Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?Journal of Clinical Pathology, 2002
- Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcomaCancer, 2000
- Evidence for a Common Etiology for Endometrial Carcinomas and Malignant Mixed Mullerian TumorsGynecologic Oncology, 1998
- Adenocarcinoma of the Endometrium: Survival Comparisons of Patients with and without Pelvic Node SamplingGynecologic Oncology, 1995
- Carcinosarcoma of the uterus: A 40-year experience from the State of MissouriGynecologic Oncology, 1984
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958